• 
• 
• 
• 
• 
• 

Phase I

Phase I studies require rapid recruitment and completion. Esoterix Clinical Trials Services provides the laboratory support for these studies, combined with the convenience and compliance of a large central laboratory.

Esoterix Clinical Trials Services provides phase I services in Belgium and through several strategically located laboratories in the United States. Data management capabilities, such as the custom formatting of electronic data, are also offered.

In addition to safety testing, Esoterix Clinical Trials Services can also provide esoteric testing for phase I studies. Our broad menu of esoteric testing capabilities includes flow cytometry, image analysis, immunohistochemistry, immunoassays, and polymerase chain reaction (PCR) assays.

Our network of local laboratories handling phase I trials provides the timely turnaround and accelerated study setup required to conduct a successful trial. Our dedicated phase I network provides scientific expertise and flexibility to help clients meet study schedules and turnaround times. Esoterix Clinical Trials Services' regional laboratories involved in phase I studies in the US are CLIA and CAP – certified and comply with applicable GCP regulatory guidelines. Our phase I network can also perform testing under GLP guidelines when appropriate, providing a standardized testing environment across our local phase I laboratories. Our European facility complies with EN45001.

Our regional facilities follow the LabCorp corporate quality assurance guidelines to help ensure high accuracy and precision. Stringent precision and process control guidelines are incorporated, along with recent advances in automation and specimen tracking. Esoterix Clinical Trials Services also archives Phase I data for 15 years.

Esoterix Clinical Trials Services' capabilities also extend beyond phase I studies to offer services to support phases II through IV of drug development. Choosing Esoterix Clinical Trials Services to support your study throughout the drug development process allows for ease of data transfer between phases. As a result, one laboratory can handle your entire drug development program, saving you time and reducing data errors.